Mansur Nariman, Weiss Avraham, Beloosesky Yichayaou
Department of Geriatrics, Pharmacy Services, Rabin Medical Center, Beilinson Campus, Sackler School of Medicine, Tel Aviv University, Petach Tikvah, Israel.
Ann Pharmacother. 2008 Jun;42(6):783-9. doi: 10.1345/aph.1L070. Epub 2008 Apr 29.
Medication regimens are constantly modified and updated during a patient's hospitalization. These modifications and those made after discharge might increase the risk for nonadherence, polypharmacy, and poor outcomes among elderly patients.
To investigate the extent of in-hospital modification of medication regimens of elderly patients and its relationship to medication adherence as well as one-month postdischarge drug regimen modifications and to examine the relationship of the modifications, adherence, and polypharmacy to mortality and readmissions 3 months postdischarge.
Clinical and demographic data, postdischarge medication modifications, and adherence were prospectively obtained in 212 elderly patients. Inhospital drug regimen modifications were retrospectively recorded.
The average +/- SD in-hospital medication regimen modification rate was 49.8% +/- 28.4. No modifications were found in 9.7% of the patients. Using demographic and clinical parameters, we performed regression analysis and found that patients who were admitted with polypharmacy, discharged home, and cognitively normal experienced fewer medication modifications (p < 0.05). At one month postdischarge, the average medication regimen modification rate was 37.5% +/- 25.4. In- and posthospital modifications were directly correlated (p = 0.047). Three months postdischarge, 17 patients had died and 50 had been readmitted. The independent risk factors for mortality were in-hospital modification rate of 50% or greater (OR 6.4; 95% CI 1.3 to 29.7), impaired cognition (OR 4.2; 95% CI 1.4 to 12.3), and each chronic disease (OR 1.2; 95% CI 1 to 1.5). No relationships were found between in-hospital medication regimen modifications and readmissions or with postdischarge modifications, adherence, and polypharmacy to mortality and readmissions.
Hospitalization of elderly patients is characterized by extensive medication regimen modifications, which are directly correlated with postdischarge modifications and may indicate an increased risk of mortality.
在患者住院期间,药物治疗方案会不断调整和更新。这些调整以及出院后的调整可能会增加老年患者不依从治疗、用药过多和预后不良的风险。
调查老年患者住院期间药物治疗方案的调整程度及其与用药依从性的关系,以及出院后1个月的药物治疗方案调整情况,并研究这些调整、依从性和用药过多与出院后3个月死亡率和再入院率的关系。
前瞻性收集212例老年患者的临床和人口统计学数据、出院后药物治疗方案的调整情况及依从性。回顾性记录住院期间的药物治疗方案调整情况。
住院期间药物治疗方案的平均调整率为49.8%±28.4%。9.7%的患者未进行调整。利用人口统计学和临床参数进行回归分析,发现入院时用药过多、出院回家且认知正常的患者药物治疗方案调整较少(p<0.05)。出院1个月时,药物治疗方案的平均调整率为37.5%±25.4%。住院期间和出院后的调整呈直接相关(p=0.047)。出院3个月时,17例患者死亡,50例患者再次入院。死亡率的独立危险因素包括住院期间调整率达到或超过50%(比值比6.4;95%置信区间1.3至29.7)、认知障碍(比值比4.2;95%置信区间1.4至12.3)以及每种慢性病(比值比1.2;95%置信区间1至1.5)。未发现住院期间药物治疗方案调整与再入院率之间的关系,也未发现出院后调整、依从性和用药过多与死亡率及再入院率之间的关系。
老年患者住院的特点是药物治疗方案广泛调整,这与出院后的调整直接相关,可能预示着死亡风险增加。